Previous studies have established Grem1 as a critical regulator in the development of NAFLD and liver fibrosis by its inhibition of bone morphogenetic protein (BMP) signaling [49,50]. The gene discussed is GREM1; the disease is metabolic dysfunction-associated steatotic liver disease.